|
|
ORACEA® (OR-AY-SHA) (doxycycline, USP) Capsule Delivers Visible Results
The patients pictured were actual participants in the rosacea treatment clinical trials for ORACEA®.
Individual results may vary.†
|
PATIENT ID#: 301.115
†In this clinical trial, many study subjects demonstrated improvements in their rosacea over course of the study, and approximately 30% were clear or almost clear of disease symptoms by the end of the study.
This study was Phase III, parallel-group, multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of ORACEA®, in which patients received
40 mg of ORACEA® or a placebo for 16 weeks.
|
 |
|
†In this clinical trial, many study subjects demonstrated improvements in their rosacea over course of the study, and approximately 14% were clear or almost clear of disease symptoms by the end of the study.
This study was Phase III, parallel-group, multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of ORACEA®, in which patients received
40 mg of ORACEA® or a placebo for 16 weeks.
|
*For insured patients only. Certain limitations apply. Click here for program details.
ORACEA® (OR-AY-SHA) Care Card Program Information
1. This offer is not valid in Massachusetts and for prescriptions reimbursed in whole or in part by Medicaid, Medicare, or federal or state programs (including any state prescription drug program). 2. This card is good for use only with an ORACEA® prescription at the time the prescription is filled by the pharmacist and dispensed to the patient. 3. Offer good only in the USA at participating retail pharmacies and cannot be redeemed at government-subsidized clinics. 4. Galderma Laboratories, L.P., reserves the right to rescind, revoke or amend this offer without notice at any time. 5. The selling, purchasing, trading or counterfeiting of this card is prohibited by law. 6. Cash value is 1/100th of 1 cent. 7. By using this card, you demonstrate that you understand and agree to comply with the terms and conditions of this offer as forth on this card.
Effective January 2012, the Oracea Care Card will have a maximum benefit of $325. Program expires December 31, 2012. For processing questions, please call 1-877-318-9527 from 8am – 9pm ET, Monday through Friday, and 9am – 5pm ET, Saturday.
METROGEL® 1% Co-pay Card Program Information
Offers not valid for prescriptions reimbursed under any federal or state healthcare program, including any state medical assistance programs. Offer void where prohibited by law, taxed or restricted. Offer good only in the USA. Galderma reserves the right to rescind, revoke, or amend this offer without notice at any time. Restricted in Massachusetts to prescriptions that are not reimbursed by any third-party payor. Offer good for savings up to $80.
For processing questions, please call 1-866-954-5516.
|
ORACEA® (OR-AY-SHA) Care Card Program Information
1. This offer is not valid in Massachusetts and for prescriptions reimbursed in whole or in part by Medicaid, Medicare, or federal or state programs (including any state prescription drug program). 2. This card is good for use only with an ORACEA® prescription at the time the prescription is filled by the pharmacist and dispensed to the patient. 3. Offer good only in the USA at participating retail pharmacies and cannot be redeemed at government-subsidized clinics. 4. Galderma Laboratories, L.P., reserves the right to rescind, revoke or amend this offer without notice at any time. 5. The selling, purchasing, trading or counterfeiting of this card is prohibited by law. 6. Cash value is 1/100th of 1 cent. 7. By using this card, you demonstrate that you understand and agree to comply with the terms and conditions of this offer as forth on this card.
Program expires December 31, 2012. For processing questions, please call 1-877-318-9527 from 8am – 9pm ET, Monday through Friday, and 9am – 5pm ET, Saturday.
METROGEL® 1% Co-pay Card Program Information
Offers not valid for prescriptions reimbursed under any federal or state healthcare program, including any state medical assistance programs. Offer void where prohibited by law, taxed or restricted. Offer good only in the USA. Galderma reserves the right to rescind, revoke, or amend this offer without notice at any time. Restricted in Massachusetts to prescriptions that are not reimbursed by any third-party payor. Offer good for savings up to $80.
For processing questions, please call 1-866-954-5516.
|
 |
Important Safety Information: ORACEA®
ORACEA ® is indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients. You may experience intestinal upsets, sore throat or sinus infections/sinusitis when taking ORACEA ®. Do not take ORACEA ® if you are allergic to tetracyclines, and it may cause harm to a developing fetus; so do not take ORACEA ® if you are pregnant or breastfeeding. When taking ORACEA ®, stay out of direct or artificial sunlight, and make sure you tell your doctor if you have stomach or GI problems, kidney disease, have a yeast or fungal infection, take blood thinners, take oral contraceptives, or take medicine to treat acne, psoriasis or seizures. ORACEA ® does not treat bacterial infections. Use ORACEA ® only as prescribed by your doctor. For more information about ORACEA ®, see Full Prescribing Information. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
|